Filing Details

Accession Number:
0001415889-24-026708
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-11-13 16:40:07
Reporting Period:
2024-11-11
Accepted Time:
2024-11-13 16:40:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1727196 Scholar Rock Holding Corp SRRK Biological Products, (No Disgnostic Substances) (2836) 823750435
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1834528 L. Jing Marantz 301 Binney Street
Cambridge MA 02142
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-11-11 2,105 $8.59 74,960 No 4 M Direct
Common Stock Disposition 2024-11-11 2,105 $30.00 72,855 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2024-11-11 2,105 $0.00 2,105 $8.59
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
138,520 2032-11-14 No 4 M Direct
Footnotes
  1. These transactions were effected by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted on April 19, 2024.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.03, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  3. The shares underlying this option vest over four years with the first installment vested on November 9, 2023 and the remainder vesting in twelve quarterly installments thereafter, provided the reporting person continues to have a service relationship with the Issuer as of the applicable vesting date.